Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Christine de Vries - Scheidegger
Head of Market Development, Corporate R&D at Elsevier
About the author:
Christine has over 10 years of experience in the publishing industry working at Elsevier, with a focus on supporting Corporate R&D customers’ needs with Elsevier’s research intelligence solutions Scopus, SciVal and ScienceDirect. Her roles have involved delivering global product launches across industries such as Pharma and Life Sciences and she has commercial executive experience with real customer focus, market knowledge and business acumen. Prior to joining Elsevier, she worked as a management associate for GE Money. Christine holds a Bachelor of Science from Trinity University.
Posts by Christine de Vries - Scheidegger
Posted on January 18th, 2017 in Pharma R&D
Last year we discussed the new Cancer Moonshot, a White House initiative being headed by out-going Vice-President Joe Biden. Continue reading “Cancer Moonshot: Report Research Trends Released” »
Posted on August 17th, 2016 in Pharma R&D
“Last year, Vice President Biden said that with a new moonshot, America can cure cancer. Last month, he worked with this Congress to give scientists at the National Institutes of Health the strongest resources that they’ve had in over a decade. So tonight, I’m announcing a new national effort to get it done,” said President Obama in his final State of the Union address in January 2016.